Skip to main content
. 2018 Mar 30;38(4):331–337. doi: 10.3343/alm.2018.38.4.331

Table 2. Comparison of biomarkers according to TE grade.

Variable F0/1 (N = 129) F2 (N = 16) F3/4 (N = 28) P*
F0/1 vs F2 F0/1 vs F3/4 F2 vs F3/4
ELF 8.7 (8.2–9.2) 9.8 (9.3–10.1) 10.2 (9.4–11.8) 0.0001 < 0.0001 0.0831
 None to mild (%) 4 (3.1) 0 (0.0) 0 (0.0) 0.0010 < 0.0001 0.160
 Moderate (%) 112 (86.8) 9 (56.2) 11 (39.3)
 Severe (%) 13 (10.1) 7 (43.7) 17 (60.7)
M2BPGi (COI) 0.4 (0.3–0.6) 0.8 (0.6–1.3) 0.9 (0.6–1.6) < 0.0001 < 0.0001 0.4494
 Negative (%) 126 (97.7) 9 (56.3) 14 (50.0) < 0.0001 < 0.0001 0.059
 Positive (%) 3 (2.3) 7 (43.7) 14 (50.0)
Galectin-3 (ng/mL) 10.6 (8.5–13.2) 11.3 (8.9–13.3) 13.1 (10.8–16.3) 0.3618 0.0036 0.2831
sST2 (ng/mL) 31.0 (24.0–36.4) 37.0 (27.1–41.6) 42.9 (33.3–74.9) 0.1331 < 0.0001 0.0192

Data are presented as median (interquartile range) or number (percentage).

*Mann-Whitney U test (galectin-3 and sST2); chi-square test or Fisher's exact test (ELF and M2BPGi).

Abbreviations: TE, transient elastography; ELF, enhanced liver fibrosis; M2BPGi, Mac-2-binding protein glycosylation isomer; sST2, soluble suppression of tumorigenicity 2.